PMCB

PharmaCyte Biotech Inc

NASDAQ: PMCB · HEALTHCARE · BIOTECHNOLOGY

$0.45

+1.79% today

Updated 2026-09-11

Market cap

$4.75M

P/E ratio

—

P/S ratio

12,904.41x

EPS (TTM)

$-2.77

Dividend yield

—

52W range

$0 – $2

Volume

0.1M

Market cap

$4.75M

P/E ratio

—

P/S ratio

12,904.41x

EPS (TTM)

$-2.77

Dividend yield

—

52W range

$0 – $2

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.0

Quality

3.0

Profitability

5.0

Valuation

C+

2/9

Piotroski F-Score

Weak

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →251 stocks currently score above 75

Price targets

Analyst target

—

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Piotroski 2/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-1.39M

Key financials

Revenue Net Income Free Cash Flow

Metric	2023	2024	2025	2026	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-4.32M	$333763.00	$30.66M	$-19.42M	$-4.39M
EPS	—	—	—	—	$-2.77
Free cash flow	$-3.79M	$-2.15M	$-2.98M	$-5.15M	$-1.39M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
PMCB	$4.75M	26	4.3	3.0	5.0	6.0	—	Avoid
LLY	$994.92B	76	9.3	10.0	5.0	6.0	—	Strong Buy
JNJ	$640.02B	59	4.7	8.5	2.7	6.0	-88.93%	Buy
ABBV	$454.36B	73	6.7	8.5	4.0	5.0	-69.36%	Strong Buy
MRK	$355.10B	36	4.0	4.5	2.0	5.0	-73.74%	Hold
UNH	$340.27B	62	7.3	5.5	4.7	6.0	-16.10%	Buy

Smart narrative

PharmaCyte Biotech Inc trades at $0.45. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score.

Frequently asked questions

What is PharmaCyte Biotech Inc's stock price?

PharmaCyte Biotech Inc (PMCB) trades at $0.45, on a P/S of 12,904.4x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.

Is PharmaCyte Biotech Inc overvalued?

PharmaCyte Biotech Inc carries a Smart Value Score of 26/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio12,904.41x

ROE-8.42%

Beta0.66

50D MA$0.58

200D MA$0.73

Shares out0.01B

Float0.01B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

PMCB vs LLY →PMCB vs JNJ →PMCB vs ABBV →Stock screener →